Côte d'Ivoire vs Western Pacific (WHO region): Previously treated cases tested for RR-/MDR-TB

Côte d'Ivoire
100.0%
in 2024
Western Pacific (WHO region)
86.0%
in 2024
Côte d'Ivoire rank
1st
Western Pacific (WHO region) rank
3rd

Previously treated cases tested for RR-/MDR-TB over time

  • Côte d'Ivoire
  • Western Pacific (WHO region)
020406080100200520142024

How they compare

Côte d'Ivoire currently reports 100.0% against 86.0% in Western Pacific (WHO region), a difference of 14.0%.

That makes Côte d'Ivoire's figure about 1.2 times Western Pacific (WHO region)'s.

The two have swapped places 9 times across 17 shared years of data; in 2005 it was Western Pacific (WHO region) ahead.

Côte d'Ivoire ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.

Côte d'Ivoire has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Côte d'Ivoire Western Pacific (WHO region) Difference Ahead
2000s 8.6% 1.2% 7.4% Côte d'Ivoire
2010s 60.3% 54.1% 6.2% Côte d'Ivoire
2020s 98.4% 89.2% 9.2% Côte d'Ivoire

Averages of every year both report within each decade.

Frequently asked questions

Which has higher previously treated cases tested for rr-/mdr-tb, Côte d'Ivoire or Western Pacific (WHO region)?
Côte d'Ivoire, at 100.0% against 86.0% in Western Pacific (WHO region) as of 2024.
What is the difference in previously treated cases tested for rr-/mdr-tb between Côte d'Ivoire and Western Pacific (WHO region)?
14.0%, with Côte d'Ivoire ahead.
How many years of comparable data are there for Côte d'Ivoire and Western Pacific (WHO region)?
17 years are reported by both, from 2005 to 2024.
How do Côte d'Ivoire and Western Pacific (WHO region) rank globally for previously treated cases tested for rr-/mdr-tb?
Côte d'Ivoire ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Côte d'Ivoire vs Western Pacific (WHO region): Previously treated cases tested for RR-/MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 14 September 2026, from https://health.statizoid.com/compare/previously-treated-cases-tested-for-rr-mdr-tb-percent/cote-d-ivoire/western-pacific-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/previously-treated-cases-tested-for-rr-mdr-tb-percent/cote-d-ivoire/western-pacific-who-region/">Côte d'Ivoire vs Western Pacific (WHO region): Previously treated cases tested for RR-/MDR-TB</a> — Statizoid

About this data

Indicator
Previously treated cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
193 places, 3,089 data points, 2005–2024
Last refreshed